Jane Reed

Digital

Speed and safety in drug development and discovery represent some of the biggest challenges and opportunities facing life sciences companies today.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.